IBIO-100

N/A

Report date: 2024/02/06 13:05:22

Base Information

Drug NameIBIO-100
Drug Alias NameCFB-03IBIO-100IBIO CFB03
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionAngiogenesis inhibitorsGelatinases inhibitors
TargetsGelatinases
Therapy Area/IndicationsScleroderma, SystemicIdiopathic Pulmonary Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMedical University Of South Carolina
China Registration ClassN/A

Develop Information

Active CompaniesIbio Inc
Inactive CompaniesN/A
Active IndicationsScleroderma, SystemicIdiopathic Pulmonary Fibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A